IART News and Press, Integra LifeSciences Holdings Corporation From 02/28/24

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunc...

PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare&#...

2023-12-26 08:35:55 ET Summary Integra LifeSciences is a leader in neurosurgical solutions, regenerative technologies, and surgical instrumentation. The company's shares have been coming down since the pandemic, due to lack of growth and lack of execution. Trying to ignite som...

2023-12-19 12:08:34 ET More on iShares Russell 2000 ETF: Peter Lynch Says Forget Tech Stocks, The Bargains Are Here: IWM Vs. VB IWM: Santa Rally On Steroids (Rating Downgrade) The Week On Wall Street: Holiday Edition Money market funds attract more than $50B ...

2023-12-13 06:44:42 ET More on Integra LifeSciences Holdings Integra LifeSciences: There's Value Here If They Can Stop The Unforced Errors Integra LifeSciences Holdings Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Integra LifeSciences Holdings ...

The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment. Provides a unique opportunity to build scale and capture a leadershi...

PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D., president and chief executive officer of 3D Systems Corporation, was appointed to the company ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Integra stock or options between March 11, 2019 and May 22, 2023 and would like to discuss your lega...

2023-10-27 11:29:18 ET Summary Q3 results were impacted by customer returns related to the Boston facility recall, but the Codman Specialty Surgical business performed well. The reopening of the Boston facility is on track, but facility remediation can be a complicated process, an...